In the newsNews in mediaSupporting data integrity practices

In the news |  5 May 2024

Supporting data integrity practices

In the era of digital transformation, data has become the BioPharma industry’s most valuable asset. The industry is witnessing a “gold rush” for data, with a significant focus on reusing existing data for new purposes.
In a recent article in Biopharm International, Nathalie Batoux, Product Manager, Research Innovation at IDBS, writes about the evolving data integrity practices in the biopharma industry and how to ensure the data used for artificial intelligence (AI) and machine learning (ML) analysis is of high quality.
Hear Nathalie speak about the topic below.

Read the full article on the BioPharm International website.

About IDBSContact us